Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO RESEARCH IN ONCOLOGY

July 2022

ONCOLOGY

INVESTIGATORS EXPLORE CELLULAR RESPONSE TO STRESS

Featuring: Marc Mendillo, PhD

Northwestern Medicine investigators have discovered novel mechanisms that regulate a cell’s response to molecular stressors, according to a study published in the Proceedings of the National Academy of Sciences.

The findings may help improve the understanding of how cancer and other diseases use stress response programming to survive.

“Cancers have these deranged genomes. They have mutations, they’re hyper-proliferative, and they’re subjected to chemotherapies and radiation, so these stress response genes really become critical for cancer survival,” said Marc Mendillo, PhD, assistant professor of Biochemistry and Molecular Genetics and senior author of the study.

David Amici, a student in the Medical Scientist Training Program (MSTP), was lead author of the study.

​All human cells contain adaptive signaling pathways that enable them to counteract different types of cellular and environmental stressors. However, because these stress response pathways are almost always studied individually, the mechanisms which help regulate and link these stress response pathways have remained poorly understood.

In the current study, Mendillo’s team used genome-scale fitness screening data compiled by a computational tool called FIREWORKS, which was developed by Mendillo’s laboratory, to map the stress phenotypes of more than 700 cancer cell lines, each of which has a unique burden of intrinsic stressors.

The approach revealed a network of genes promoting cellular stress responses; one gene in particular caught the investigators’ attention: HAPSTR1.

They discovered that HAPSTR1 plays a central role in cellular stress signaling and is also mechanistically induced by specific types of stressors like DNA damage, cellular starvation and proteotoxicity.

Moreover, HAPSTR1 both interacts with and is degraded by a protein called HUWE1, which has been previously implicated in different cancers and neurodevelopmental disorders. The protein is an E3 ubiquitin ligase, meaning its sole function is to hunt down specific proteins and degrade them.

Additional analysis revealed that HUWE1 and HAPSTR1 have a somewhat unconventional relationship: HUWE1 assists HAPSTR1 in controlling stress signaling and in turn, HUWE1 feeds back to promote the degradation of HAPSTR1.

“The relationship is complicated in that we know that they have this shared function because basically turning off either one results in similar types of effects,” Mendillo said.

Overall, the findings point to HAPSTR1 as a central player within a network of stress response pathways promoting cellular adaptability, according to Mendillo.

“The bottom line is we know that HAPSTR1 is promoting cellular resilience to these various types of stresses. We think this is going to be important in cancers and probably other diseases, too,” Mendillo said.​

​Co-authors include Roger Smith, an MSTP student; Claire Phoumyvong, a student in the Driskill Graduate Program in Life Sciences (DGP); Neil Lindstrom Kelleher, PhD, professor of Medicine in the Division of Hematology and Oncology and of Biochemistry and Molecular Genetics; Issam Ben-Sahra, PhD, assistant professor of Biochemistry and Molecular Genetics; and Daniel Foltz, PhD, associate professor of Biochemistry and Molecular Genetics.

Ben-Sahra, Foltz and Mendillo are members of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

This work was supported by The National Institutes of Health grants R00CA175293, R01GM111907, R35GM138364, 5P20GM103636, F30CA264513, T32GM008152; the American Cancer Society; and Kimmel Scholars, Lynn Sage Scholar, and Robert H. Lurie Comprehensive Cancer Center H Foundation Collaboration awards.

This article was originally published in the Feinberg School of Medicine News Center on July 20, 2022.
Marc Mendillo, PhD headshot
Marc Mendillo, PhD, assistant professor of Biochemistry and Molecular Genetics, was senior author of the study published in the Proceedings of the National Academy of Sciences.
​​
David Amici headshot
David Amici, a student in the Medical Scientist Training Program, was lead author of the study published in the Proceedings of the National Academy of Sciences.
​

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​
Call 844.344.6663
Find an NM ONCOLOGIST

You May Also Like

B-Cell Acute Illustration

February 2021

ONCOLOGY
Identifying Therapeutic Targets for B-cell Acute Lymphoblastic Leukemia
Image of Lurie Cancer Center Building

September 2021

ONCOLOGY
Lurie Cancer Center Receives Prostate Cancer SPORE from the NCI
Epigenetic Markers Illustration

December 2020

ONCOLOGY
Identifying Oncogenes through Epigenetic Markers

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties